Global Medical Director - Hepatology (Steatotic Liver Disease)

GSK

10d

About The Position

The Global Medical Director role is a unique opportunity for an experienced, innovative, and proactive medical professional to facilitate the understanding of the value of our medicines and vaccines, the science behind them and the public impact they can offer. This is accomplished by developing and implementing the global medical scientific strategic plan to generate insights, shape optimal care through scientific dialogue and education and delivering impact by generating and communicating the evidence and delivering solutions to close the gaps. The Global Medical Director for Hepatology will work in a thriving team of medical business leaders where people will be inspired to drive towards achieving our goals of getting Ahead of Disease Together and positively impacting patient and population health outcomes globally.

Requirements

MD/MBBS/PharmD or PhD in clinical / scientific discipline.
Considerable experience in Medical Affairs including roles in LOCs and supporting pre/peri launch phases of assets.
Proven clinical or scientific experience in hepatology.
Strong interpersonal, verbal, and written communication skills in English.
Ability to prioritise and manage multiple projects, budgets, and interactions simultaneously.
Ability to thrive in a fast paced, innovative environment while remaining flexible, proactive, resourceful, and efficient.
Outstanding listening, communication & collaborative team working and leadership skills, as the role involves interface with a wide range of stakeholders internally and externally.
Demonstrated matrix leadership in previous roles with ability to build strong networks, manage complexity and cultural diversity.

Nice To Haves

Previous clinical or scientific experience in Steatotic Liver Disease (SLD)
Robust understanding of internal and external codes of practice and regulations (certification where applicable)
Experience in medical support for briefing documents for regulatory interactions and payor dossiers.
General understanding of statistics, safety, regulatory requirements.
Demonstrated experience with developing global or local medical strategies and asset launches, especially within a priority market.
Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimise medical implementation of innovation.

Responsibilities

Thinks globally, while deeply understands priority LOC (Local Operating Company) needs and success measures. This is accomplished through extensive partnership and collaboration with LOC teams to understand landscape, market value drivers, and timelines for required deliverables.
Partners with above-country and country colleagues to drive, integrate and prioritise key insights to inform global medical plans and lifecycle strategy.
Engages across the ecosystem, including R&D, Evidence Generation, Global Product Strategy, and country teams to support identification and prioritization of evidence generation needs to close gaps and support the optimization of clinical care.
Participate and shape the relevant asset(s) medical strategy as a member of the Global Medical Asset Team (GMAT)
Leads the creation and implementation of an integrated external medical communications plan which is optimized to deliver external impact and considers all channels (including publications and congresses) and key market needs.
Partner with Global Product Strategy, Market Access, and core country teams to support/advise on core claims.
Ensures colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their training by partnering on the creation and delivery of high-quality scientific materials for both internal and external use.
Drives excellence in external engagement with key stakeholders (e.g. HCP’s, Patients, Payors and Regulators) globally and in partnership with core countries.
Ensure appropriate medical governance oversight of all deliverables, inclusive of risk assessment and mitigation plan associated with deliverables/strategies.
Development of deep subject matter expertise on the product and therapy area as well as the ability to drive proactive strategic planning.